Priority Date: 09.08.12 (US 201261681447P)

METHODS OF TREATING CANCER USING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE

  • Application ID: EP13751007
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 1001 - 5000 employees
Company dna jones day
operating since 1893
1250.2
Headquarter in Cleveland and 38 offices
active in Legal Services

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING). We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Engel Patentanwaltskanzlei, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 174 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 09.08.2012 - Priority Date (US 201261681447P)
  • 13.02.2014 - Publication A1 (WO2014025960)
  • 17.06.2015 - Publication A1 (EP2882442)

IPC Classification